Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Market Information
Omada common stock is traded on Nasdaq, under the symbol “OMDA.”
Shareholder Information
As of March 3, 2026, we had approximately 52 shareholders of record. This does not include persons whose stock is in nominee or “street name” accounts through brokers. We are unable to estimate the total number of stockholders represented by these record holders.
Dividend Policy
We have never declared or paid cash dividends on our common stock. We currently intend to retain all available funds and any future earnings for use in the operation of our business and do not anticipate paying any dividends on our common stock in the foreseeable future.
68
Table of Contents
Securities Authorized for Issuance Under Equity Compensation Plans
The information called for by this Item will be set forth in our Proxy Statement for the 2026 Annual Meeting of Stockholders to be filed with the SEC within 120 days of the fiscal year ended December 31, 2025.
Issuer Purchases of Equity Securities
We did not purchase any of our registered equity securities during the period covered by this report.
Stock Performance
The following shall not be deemed incorporated by reference into any of our other filings under the Exchange Act or the Securities Act.
The following data and graph show a comparison of the cumulative total shareholder return for our common stock, the S&P 500 Index, and S&P 500 Healthcare Index from June 6, 2025 (the date that our common stock commenced trading on the NYSE) through December 31, 2025. This data assumes simultaneous investments of $100 on June 6, 2025 and reinvestment of any dividends. The stockholder return shown in the graph below is not necessarily indicative of future performance, and we do not make or endorse any predictions as to future stockholder returns.
Company Index 6/6/2025 6/30/2025 7/31/2025 8/31/2025 9/30/2025 10/31/2025 11/30/2025 12/31/2025
Omada Health $ 100.00 $ 79.57 $ 76.17 $ 103.00 $ 96.13 $ 106.83 $ 81.43 $ 68.61
S&P 500 Index $ 100.00 $ 103.41 $ 105.65 $ 107.66 $ 111.47 $ 114.00 $ 114.14 $ 114.08
S&P 500 Healthcare $ 100.00 $ 100.62 $ 97.16 $ 102.26 $ 103.91 $ 107.50 $ 117.32 $ 115.55
Unregistered Sales of Equity Securities
All unregistered securities issued and sold during the year ended December 31, 2025 are disclosed in our Quarterly Reports on Form 10-Q for the quarters ended June 30, 2025 and September 30, 2025.
Use of Proceeds
69
Table of Contents
On June 9, 2025, we completed our IPO, in which we issued and sold 9,085,000 shares of common stock, which includes the exercise in full by the underwriters of their option to purchase from us 1,185,000 shares of our common stock, at a public offering price of $19.00 per share. We received proceeds of approximately $ 151.6 million, after deducting underwriting discounts and commissions of $12.0 million and estimated offering expenses of $9.0 million. All shares sold were registered pursuant to a registration statement on Form S-1 (File No. 333-287156), as amended (the “Registration Statement”), declared effective by the U.S. Securities and Exchange Commission on June 5, 2025. Morgan Stanley & Co, LLC, Goldman Sachs & Co. LLC, and J.P. Morgan Securities LLC acted as representatives of the underwriters for the offering. The offering terminated after the sale of all securities registered pursuant to the Registration Statement. No payments for such expenses were made directly or indirectly to (i) any of our officers or directors or their associates, (ii) any persons owning 10% or more of any class of our equity securities, or (iii) any of our affiliates.
There has been no material change in the expected use of the net proceeds from our IPO as described in our prospectus.
Item 6. [ Reserved ]
70
Table of Contents